SCHEMBL6137034

SCHEMBL6137034

CCOC(=O)c1cc(C)c(C#N)c(C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.55
CA1 P00915 3/20 0.55
CA2 P00918 3/20 0.55
CA7 P43166 3/20 0.55
CA9 Q16790 3/20 0.55
CA14 Q9ULX7 3/20 0.55
KDM4E B2RXH2 6/20 0.54
ALDH1A1 P00352 6/20 0.54
HSD17B10 Q99714 2/20 0.54
HPGD P15428 2/20 0.54
GLA P06280 1/20 0.51
ATM Q13315 1/20 0.51
MAPT P10636 3/20 0.50
TP53 P04637 1/20 0.50
GAA P10253 1/20 0.50
ALOX15 P16050 1/20 0.50
APOBEC3G Q9HC16 1/20 0.50
KMT2A Q03164 2/20 0.47
ESR1 P03372 3/20 0.46
ESR2 Q92731 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1515896 0.81 CA12 (0.50) CA12CA1CA2CA7CA9
SCHEMBL13193177 0.78 CA12 (0.54) CA12CA1CA2CA7CA9
SCHEMBL28289517 0.78 CA12 (0.54) CA12CA1CA2CA7CA9
SCHEMBL6137032 0.78 KDM4E (0.58) KDM4EALDH1A1HSD17B10HPGDGLA
SCHEMBL5987476 0.78 CYP3A4 (0.49) CA12CA1CA2CA7CA9
SCHEMBL1664013 0.78 CA12 (0.75) CA12CA1CA2CA7CA9
SCHEMBL28692452 0.77 CA12 (0.62) CA12CA1CA2CA7CA9
SCHEMBL869061 0.77 ESR1 (0.71) CA12CA1CA2CA7CA9
SCHEMBL25276513 0.76 CA12 (0.60) CA12CA1CA2CA7CA9
SCHEMBL7930642 0.76 CA12 (0.60) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1029851-B1 PIPERAZINE COMPOUNDS AND MEDICINAL USE THEREOF MITSUBISHI PHARMA CORP (JP) 2005-04-20 EP disclosed
US-6455528-B1 TUMOR NECROSIS FACTOR ANTAGONIST AND/OR INTERLEUKIN PROMOTER; ANTIALLERGENS, ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASE TREATMENT MITSUBISHI PHARMA CORPORATION (JP) 2002-09-24 US disclosed